Levothyroxine use and bone loss: Longitudinal analysis among euthyroid men and women from the Baltimore Longitudinal Study of Aging
Bone · 2027
DOI: 10.1016/j.bone.2026.118100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2027. Verfasst von Elena Ghotbi und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Hauptthemen laut MEDLINE: Thyroxine, Aging. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Levothyroxine (LT4) is among the most frequently prescribed medications worldwide and the leading cause of thyrotoxicosis, a known risk factor for lower bone density and fracture. However, the skeletal consequences of LT4 use in biochemically euthyroid individuals remain poorly characterized. METHODS: Data are from the Baltimore Longitudinal Study of Aging (BLSA). Eligible participants were euthyroid at all study visits and either consistently or never used LT4 throughout follow-up. Sex-stratified propensity score matching (1:3 ratio) balanced LT4-users and non-users on demographic, physiologic, medical and sex-specific factors. BMD was measured by dual-energy X-ray absorptiometry and linear mixed-effects models with piecewise linear age splines were used to estimate age-specific BMD trajectories. RESULTS: We included 108 men (31 LT4-users, 77 non-users) and 202 women (53 LT4-users, 149 non-users) analyzed in four age-strata: (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- National Institute of Aging, NIH, Baltimore, MD, United States.
- School of Medicine, Department of Medicine, Division of Geriatric Medicine and Gerontology, Johns Hopkins Center on Aging and Health, Johns Hopkins University, Baltimore, MD, United States.
- The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: sdemehr1@jhmi.edu.
- Division of Endocrinology, Diabetes and Metabolism, The Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Zitieren
APA
Ghotbi, E., McGready, J., Hadidchi, R., Ibad, H. A., Simonsick, E. M., Xue, Q. L., Demehri, S., & Mammen, J. S. (2027). Levothyroxine use and bone loss: Longitudinal analysis among euthyroid men and women from the Baltimore Longitudinal Study of Aging. Bone. https://doi.org/10.1016/j.bone.2026.118100
Vancouver
Ghotbi E, McGready J, Hadidchi R, Ibad HA, Simonsick EM, Xue QL, et al. Levothyroxine use and bone loss: Longitudinal analysis among euthyroid men and women from the Baltimore Longitudinal Study of Aging. Bone. 2027. doi:10.1016/j.bone.2026.118100
BibTeX
@article{Ghotbi2027,
author = {Ghotbi, Elena and McGready, John and Hadidchi, Roham and Ibad, Hamza Ahmed and Simonsick, Eleanor M and Xue, Qian-Li and Demehri, Shadpour and Mammen, Jennifer S},
title = {Levothyroxine use and bone loss: Longitudinal analysis among euthyroid men and women from the Baltimore Longitudinal Study of Aging},
journal = {Bone},
year = {2027},
doi = {10.1016/j.bone.2026.118100}
}
EUVIMED